New Hope for Alzheimer's Targets Tau | Tulsa News

Tulsa News Today | 2 Min News | The Daily News Now! · Jul 14, 2026 · 1m

Scientists are turning the spotlight to tau protein in Alzheimer’s, with a new experimental drug called diranersen aiming to slash tau production at the source—instead of just clearing amyloid. Injected directly into the spinal fluid, this antisense oligonucleotide tells genes to dial back tau output, giving the brain’s cleanup crew a better chance. Early trial results surprised researchers: the lowest dose, given every six months, showed the strongest effect. Experts call it promising but caution it’s early days. This breakthrough could reignite interest in tau-targeting therapies, alongside…